TAP
CNMD icon

Tounjian Advisory Partners’s CONMED CNMD Stock Holding History

Tounjian Advisory Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373 Buy
+11
New +$396 ﹤0.01% 726

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Tounjian Advisory Partners's CNMD Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in CONMED (CNMD) in Q2 2026: 11 shares worth $373. The stake represents ﹤0.01% of the portfolio and ranks #726 among its holdings.

101 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Tounjian Advisory Partners held 11 shares of CONMED worth $373 as of Q2 2026.
  • CONMED was a new Tounjian Advisory Partners position in Q2 2026.
  • CONMED made up ﹤0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #726 holding.
  • 101 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.